[Structural characterization of PCP-Ⅰ from Poria as vaccine adjuvant and its hydrolytic oligosaccharide]

Zhongguo Zhong Yao Za Zhi. 2023 Aug;48(16):4429-4437. doi: 10.19540/j.cnki.cjcmm.20230124.201.
[Article in Chinese]

Abstract

Poria is an important medical herb in clinic. The authors isolated a polysaccharide(PCP-Ⅰ) from Poria in previous studies, which is composed of galactose, mannose, fucose and glucose. PCP-Ⅰ exhibited significant adjuvant effects on H1N1 influenza vaccine, hepatitis B surface antigen and anthrax protective antigen, and its adjuvant activity was stronger than aluminium adjuvant. However, little is known about the chemical structure of PCP-Ⅰ at present. In this study, weak acid hydrolysis was used to obtain the backbone oligosaccharide of PCP-Ⅰ. Then periodate oxidation, Smith degradation, methylation analysis, Fourier transform infrared spectroscopy(FT-IR), nuclear magnetic resonance(NMR) and gas chromatography-mass spectrometry(GC-MS) were performed to investigate the chemical structural features of PCP-Ⅰ and its hydrolytic oligosaccharide(PCP-Ⅰ-hy-1). These results suggested that the backbone of PCP-Ⅰ was composed of galactose with α anomeric carbon and β anomeric carbon. The linking residues of galactan are(1→),(l→6) and(1→2,6).

Keywords: Poria; chemical structure; oligosaccharide; polysaccharide; vaccine adjuvant.

Publication types

  • English Abstract

MeSH terms

  • Adjuvants, Vaccine
  • Carbon
  • Galactose
  • Hydrolysis
  • Influenza A Virus, H1N1 Subtype*
  • Oligosaccharides
  • Polysaccharides / chemistry
  • Poria*
  • Spectroscopy, Fourier Transform Infrared

Substances

  • Adjuvants, Vaccine
  • Galactose
  • Polysaccharides
  • Oligosaccharides
  • Carbon